DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
-19.51%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$201M
AUM Growth
+$201M
(-17%)
Cap. Flow
+$14.1M
Cap. Flow
% of AUM
7.01%
Top 10 Holdings %
Top 10 Hldgs %
47.8%
Holding
87
New
12
Increased
27
Reduced
13
Closed
4
Top Buys
| 1 |
iShares Biotechnology ETF
IBB
|
$3.74M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$1.85M |
| 3 |
LOXO
Loxo Oncology, Inc
LOXO
|
$1.68M |
| 4 |
Viking Therapeutics
VKTX
|
$1.37M |
| 5 |
CNCE
Concert Pharmaceuticals, Inc.
CNCE
|
$1.33M |
Top Sells
| 1 |
BioCryst Pharmaceuticals
BCRX
|
$1.51M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
$1.37M |
| 3 |
Novavax
NVAX
|
$1.32M |
| 4 |
Kura Oncology
KURA
|
$1.29M |
| 5 |
IMDZ
Immune Design Corp.
IMDZ
|
$1.13M |
Sector Composition
| 1 | Healthcare | 88.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLCM
76
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $88K | 0.04% |
30,000
| – | – |
|
|
DERM
77
DELISTED
Dermira, Inc.
DERM
| $72K | 0.04% |
10,000
+5,000
| +100% | +$36K |
|
78
Oramed Pharmaceuticals
ORMP
$90.2M
| $48K | 0.02% |
+16,000
| New | +$48K |
|
|
NEOS
79
DELISTED
Neos Therapeutics, Inc
NEOS
| $45K | 0.02% |
27,500
| – | – |
|
|
IMDZ
80
DELISTED
Immune Design Corp.
IMDZ
| – | – |
-328,500
| Closed | -$1.13M |
|
|
NTGN
81
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
| – | – |
-50,000
| Closed | -$427K |
|
|
VIRX
82
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| – | – |
-373,702
| Closed | -$747K |
|
|
83
Novavax
NVAX
$1.2B
| – | – |
-700,000
| Closed | -$1.32M |
|